Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
The Compounding Pharmacy of America

The Compounding Pharmacy of America Recalls

All product recalls associated with The Compounding Pharmacy of America.

Get alerts for this brand

Recall Summary

Total Recalls

709

Past Year

43

Class I (Serious)

3

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 581–600 of 709 recalls

Morphine Fentanyl Bupivacaine Solution (Compounding Pharmacy) - sterility (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Clonidine Solution (Compounding Pharmacy) - sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Multi-Drug Pain Solution (Compounding Pharmacy) - sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

1...28 293031 32...36

Page 30 of 36Next

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone Tri-Blend Injection (The Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Hydromorphone Clonidine Solution (Compounding Pharmacy) – sterility risk (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

MEGA-BURN Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Cyanocobalamin B-Complex Injection (Compounding Pharmacy) – sterility risk (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone Bi-Blend (Compounding Pharmacy) – Sterility Concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Clonidine Mix (Compounding Pharmacy) – Sterility Concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Alprostadil Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Hydromorphone Bupivacaine Solution (The Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine 30 mg/ml Solution (Compounding Pharmacy) – sterility risk (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Hydroxocobalamin 5,000 mcg/ml Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Fentanyl Baclofen Injectable (Compounding Pharmacy) – sterility concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine 35 mg/ml Solution (Compounding Pharmacy) – sterility concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Multi-Drug Solution (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone Cypionate Injection (Compounding Pharmacy) - Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone Cypionate Anastrazole Injection (Compounding Pharmacy) - sterility (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Nandrolone Decanoate Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone Cypionate 250mg Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America